Early research (Phase 1)Study completedNCT05148962What this trial is testingStudy of GRT-R910 COVID-19 Boost Vaccine in Healthy VolunteersWho this might be right forCOVID-19 Gritstone bio, Inc. 45
Large-scale testing (Phase 3)UnknownNCT06068569What this trial is testingStudy of the Vector Vaccine GamCovidVac for the Prevention of COVID-19 With Altered Antigenic Profile With Participation of Adult VolunteersWho this might be right forCOVID-19 Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 50
Large-scale testing (Phase 3)Study completedNCT00710866What this trial is testingInfluenza Vaccine Dose-Response in Infants and Toddlers: Immunogenicity and ReactogenicityWho this might be right forInfluenza British Columbia Centre for Disease Control 262
Early research (Phase 1)Study completedNCT01767402What this trial is testingStudy to Evaluate Safety, Reactogenicity and Immunogenicity of the Pneumococcal Protein PhtD Vaccine in Healthy AdultsWho this might be right forPneumococcal Disease GlaxoSmithKline 150
Large-scale testing (Phase 3)Study completedNCT06374394What this trial is testingA Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a COVID-19 mRNA Vaccine in Adults Aged 50 Years and AboveWho this might be right forRespiratory Syncytial Virus Infections GlaxoSmithKline 841
Early research (Phase 1)UnknownNCT03789539What this trial is testingReactogenicity, Safety and Immunogenicity of an Universal Influenza Vaccine UnifluWho this might be right forSafety Issues VA Pharma Limited Liability Company 54
Early research (Phase 1)Study completedNCT03583606What this trial is testingA Trial to Evaluate the Safety and Systems Biology Response of Ebolavirus Zaire Vaccine (ChAd3-EBO-Z)Who this might be right forEbola DiseaseImmunisation National Institute of Allergy and Infectious Diseases (NIAID) 61
Large-scale testing (Phase 3)Study completedNCT01959945What this trial is testingSafety, Reactogenicity and Immunogenicity of Flublok Quadrivalent (Recombinant Influenza Vaccine,Seasonal Formulation)Who this might be right forInfluenza Protein Sciences Corporation 219
Early research (Phase 1)Study completedNCT00545987What this trial is testingStudy of a Potential Preventive Vaccine Against HIV in Healthy VolunteersWho this might be right forHIV Infections Rockefeller University 40
Large-scale testing (Phase 3)Study completedNCT06279871What this trial is testingImmunogenicity and Safety Study of Self-amplifying mRNA COVID-19 Vaccine Administered With Influenza Vaccines in AdultsWho this might be right forCOVID-19 Arcturus Therapeutics, Inc. 1,514
Early research (Phase 1)Study completedNCT01764256What this trial is testingDose Escalation Study to Examine the Safety of the P2-VP8 Rotavirus VaccineWho this might be right forRotavirus Infection PATH 48
Early research (Phase 1)Active Not RecruitingNCT06564194What this trial is testingEvaluate JCXH-108, an mRNA-based Vaccine Against RSVWho this might be right forRespiratory Syncytial Virus (RSV)Infectious Disease Immorna Biotherapeutics, Inc. 75
Testing effectiveness (Phase 2)Study completedNCT06431607What this trial is testingFind the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older AdultsWho this might be right forInfluenza, Human GlaxoSmithKline 845
Post-approval studies (Phase 4)UnknownNCT00877357What this trial is testingSafety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination VaccineWho this might be right forDiphtheriaTetanusPertussis+2 more Shantha Biotechnics Limited 3,000
Early research (Phase 1)Looking for participantsNCT07694557What this trial is testingEvaluate the Safety, Reactogenicity and Immunogenicity of YKYY025 InjectionWho this might be right forRespiratory Syncytial Virus (RSV) Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. 180
Early research (Phase 1)Study completedNCT06375512What this trial is testingDescribe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy ParticipantsWho this might be right forHerpes Zoster Shenzhen Shenxin Biotechnology Co., Ltd 150
Early research (Phase 1)Study completedNCT01719783What this trial is testingReactogenicity, Safety, and Immunogenicity of a Live Monovalent H5N2 Influenza VaccineWho this might be right forInfluenza PATH 40
Testing effectiveness (Phase 2)Study completedNCT00385840What this trial is testingStudy to Evaluate the Immunogenicity and Safety of a Second Vaccination With the Adjuvanted Influenza Vaccine CandidateWho this might be right forInfluenza GlaxoSmithKline 678
Early research (Phase 1)Active Not RecruitingNCT06645665What this trial is testingDescribe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adult Aged 18 Years and AboveWho this might be right forRespiratory Syncytial Virus Infections Shenzhen Shenxin Biotechnology Co., Ltd 240
Large-scale testing (Phase 3)Study completedNCT00698087What this trial is testingComparison of Safety, Immuno- and Reactogenicity of MPL-Adjuvanted Recombinant Hepatitis B Vaccine to That of Engerix™-BWho this might be right forHepatitis B GlaxoSmithKline 60